0
Letters |

Lead in Calcium Supplements

Edward A. Ross, MD; Nancy J. Szabo, PhD; Ian R. Tebbett, PhD
[+] Author Affiliations

Stephen J. Lurie, MD, PhDSenior Editor: IndividualAuthor
Phil B. Fontanarosa, MDExecutive Deputy Editor: IndividualAuthor

Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
JAMA. 2000;284(24):3126-3126. doi:10-1001/pubs.JAMA-ISSN-0098-7484-284-24-jlt1227
Text Size: A A A
Published online

To the Editor: We are gratified that, in his Editorial1 accompanying our article,2 Dr Heaney agreed that the labeling of calcium supplements with their lead levels would be a sound plan. We also share his hope that calcium intake may attenuate lead absorption; however, this optimism has not yet been supported by the literature. In the study he cites,3 as well as in the more recent comprehensive findings from the same group,4 the protective effect of calcium was limited to 14-day-old chickens that were calcium deficient. Those authors suggested that the lead-calcium axis was highly complex and varied with the duration of intake. Furthermore, the data suggested that some lead absorption may be uncoupled from calcium transport. Unfortunately, the data that we cited5 failed to confirm the alleged protective effect of dietary calcium in children.

Heaney also correctly pointed out that there are a variety of dietary foods that may have a relatively high lead content. Nevertheless we view those "single source" items as being the exception rather than the rule, and US residents correctly should demand a long-term average exposure of no more than 6 µg/day. The weight of the evidence indicates that this is a realistic and attainable goal and that failure to achieve these low levels would be a public disservice. We would instead challenge manufacturers to improve their quality control and to label their products accordingly so that consumers can make informed choices. It is our hope that some of the brands without detectable levels have already accomplished this goal and thus the manufacturers have not had the motivation to include this information on their labels.

REFERENCES

Heaney  RP. Lead in calcium supplements: cause for alarm or celebration? JAMA. 2000;284:1432-1433.
Ross  EA, Szabo  NJ, Tebbett  IR. Lead content of calcium supplements. JAMA. 2000;284:1425-1429.
Fullmer  CS, Rosen  JF. Effect of dietary calcium and lead status on intestinal calcium absorption. Environ Res. 1990;51:91-99.
Fullmer  CS. Intestinal calcium and lead absorption: effects of dietary lead and calcium. Environ Res. 1991;54:159-169.
Sargent  JD, Dalton  MA, O'Connor  GT, Olmstead  EM, Klein  RZ. Randomized trial of calcium glycerophosphate-supplemented infant formula to prevent lead absorption. Am J Clin Nutr. 1999;69:1224-1230.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Heaney  RP. Lead in calcium supplements: cause for alarm or celebration? JAMA. 2000;284:1432-1433.
Ross  EA, Szabo  NJ, Tebbett  IR. Lead content of calcium supplements. JAMA. 2000;284:1425-1429.
Fullmer  CS, Rosen  JF. Effect of dietary calcium and lead status on intestinal calcium absorption. Environ Res. 1990;51:91-99.
Fullmer  CS. Intestinal calcium and lead absorption: effects of dietary lead and calcium. Environ Res. 1991;54:159-169.
Sargent  JD, Dalton  MA, O'Connor  GT, Olmstead  EM, Klein  RZ. Randomized trial of calcium glycerophosphate-supplemented infant formula to prevent lead absorption. Am J Clin Nutr. 1999;69:1224-1230.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.